Hi there,
I've gotten markedly different results when phasing using pyrho maps compared to hapmap's lifted over maps. While looking for an explanation, I've noticed that the GRCh38 maps you've released have lower overall rates of recombination than what has been reported by other methods. For example, the length of chr1 in cM averaged across all reported populations:
pyrho: 180
HapMap: 286
Fledel-Alon 2011: ~280
Coop 2012: 206
True, these are based on different samples, and recombination can vary a great deal between individuals. But HapMap's map, like yours, was based on 1KGP genomes. Why does pyrho predict fewer recombination events than LDhat (hapmap)?
Hi there,
I've gotten markedly different results when phasing using pyrho maps compared to hapmap's lifted over maps. While looking for an explanation, I've noticed that the GRCh38 maps you've released have lower overall rates of recombination than what has been reported by other methods. For example, the length of chr1 in cM averaged across all reported populations:
pyrho: 180
HapMap: 286
Fledel-Alon 2011: ~280
Coop 2012: 206
True, these are based on different samples, and recombination can vary a great deal between individuals. But HapMap's map, like yours, was based on 1KGP genomes. Why does pyrho predict fewer recombination events than LDhat (hapmap)?